Trial Profile
Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin Used in Combination With Lamivudine
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 28 Jan 2019
Price :
$35
*
At a glance
- Drugs Hepatitis B immune globulin (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Biotest Pharmaceuticals
- 17 Apr 2014 New trial record